Screen for early signs of Alzheimer's disease
( Florbetapir F18 )
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
U.S. researchers are closing in on tests that can detect biological signs of Alzheimer's disease, an advance that would improve diagnosis and help in the search for treatments for the mind-robbing disease.
A team at Eli Lilly and Co's newly acquired Avid Radiopharmaceuticals said on Tuesday its imaging agent was highly accurate as detecting a protein linked with Alzheimer's disease in a late-stage clinical trial. And a study led by Dr. Kristine Yaffe at the San Francisco Veterans Affairs Medical Center suggests a blood test could predict if a patient is at risk for dementia years before symptoms occur. Both studies, reported in the Journal of the American Medical Association, focus on biological signs of disease, or biomarkers. They are part of a broad effort by researchers to detect early Alzheimer's, the most common form of dementia.
Alzheimer's affects 26 million people globally and costs $604 billion to treat. It is diagnosed by symptoms, and only confirmed by examining the brain in an autopsy after death.
Avid is leading a three-way race with General Electric Co and Bayer AG to be the first to market an imaging agent that can detect Alzheimer's while people are still alive. This week an advisory panel of the U.S. Food and Drug Administration is reviewing Avid's bid to use the compound to rule out Alzheimer's disease. Read more: thestarphoenix.com
The research community needs support from the NIH
A list by any means dear Longevity Readers, consider that grape juice, lavender aromatherapy, music (live, preferred), music (recorded, maybe no preference), apple juice, sage, dance, therapeutic touch and vitamin B3 are now being researched for potential in treating Alzheimer’s disease (AD) and other dementias. Read more: examiner.com
No comments:
Post a Comment